.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Dow
Cipla
Accenture
UBS
QuintilesIMS
Teva
Moodys
Healthtrust
Argus Health

Generated: December 17, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Japan Patent: P2000-320420

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Eisai IncLENVIMAlenvatinib mesylateCAPSULE;ORAL206947-001Feb 13, 2015RXYesNo► Subscribe► SubscribeYY
Eisai IncLENVIMAlenvatinib mesylateCAPSULE;ORAL206947-002Feb 13, 2015RXYesYes► Subscribe► SubscribeYY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist